Resumen Analítico Especializado Empresa Agroautonoma

El mundo empresarial hoy en día se rige de diferentes maneras dentro de cada compañía, donde es importante resaltar que la innovación forma parte del crecimiento de las organizaciones siendo este un factor favorable para la economía del mundo, es así que mediante el crecimiento exponencial de las empresas la RSE forma parte de la responsabilidad que adquieren las compañías con sus directivos y sus grupos de colaboradores; es así que se busca conocer el grado de compromiso de los participantes de la empresa que trabajan en las actividades directa o indirectamente ya que ellos son parte fundamental de la implementación de los programas sociales y cuidado ambiental en la organización. La planeación estratégica es fundamental si queremos que nuestra compañía no solo conquiste los mercados nacionales sino internacionales, además logre posicionarse y mantenerse. Queda claro que todo debe ir acompañado de grandes estrategias de protección a los recursos naturales y comunicación estratégica con los grupos de colaboradores que le permitan tener un estatus social responsable, pretendemos que AGROAUTONOMA se convierta en una empresa auto sostenible con gran proyección financiera y gran responsabilidad social y ambiental.The business world today is governed in different ways within each company, where it is important to highlight that innovation is part of the growth of organizations, this being a favorable factor for the world economy, it is thus through the exponential growth of companies. companies CSR is part of the responsibility that companies acquire with their managers and their groups of collaborators; Thus, it is sought to know the degree of commitment of the participants of the company who work in the activities directly or indirectly since they are a fundamental part of the implementation of social programs and environmental care in the organization. Strategic planning is essential if we want our company not only to conquer national but international markets, as well as to position and maintain itself. It is clear that everything must be accompanied by great strategies for the protection of natural resources and strategic communication with the groups of collaborators that allow it to have a responsible social status, we want AGROAUTONOMA to become a self-sustainable company with great financial projection and great responsibility social and environmental

Estudios de Caso sobre Ciencias Agropecuarias y Rurales en el siglo XXI.

Libro científico sobre estudios de casos en el medio agropecuario y ruralCon el advenimiento del siglo XXI y el avance de los procesos de globalización, el medio rural presenta diversos cambios económicos, sociales, políticos y culturales. Lo anterior significa que el campo es un objeto de estudio altamente dinámico, complejo e inasible. las ciencias agropecuarias y rurales, en la actualidad, requieren de un abordaje sistémico e interdisciplinario que den cuenta de la heterogeneidad de situaciones y contextos que enfrenta el campo mexicano. La presente obra agrupa 18 estudios de caso, que capturan algunas fotografías de las diversas problemáticas de la ruralidad mexicana, con lo cual se pretende dar cuenta tanto de los objetivos de estudio como de la perspectiva teórico metodológico desde que estos son abordados. lo anterior tiene que ver con el hecho de que las ciencias agropecuarias y rurales manifiestan un alto grado de observación empírica, motivo por el que los estudios de caso se convierten en la perspectiva metodológica idónea que permite ir y venir de la realidad a la teoría y viceversa para la construcción de objetos de estudio. En este volumen se aborda una gran diversidad de casos, que sintetizan la heterogeneidad de enfoques y perspectivas mediante las cuales los fenómenos agropecuarios y rurales han sido abordados en el Instituto de Ciencias Agropecuarias y Rurales de la Universidad Autónoma del Estado de México, en los últimos 30 años

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

HUVN Investiga nº 18

<p>Este es el boletín de noticias de octubre de 2023 de la revista HUVN INVESTIGA del Hospital Universitario Virgen de las Nieves en Granada. El boletín incluye noticias sobre la Semana de Innovación del hospital y el reconocimiento de varios investigadores como los más influyentes del mundo. También presenta información sobre cursos de investigación, premios, becas, tesis y ensayos clínicos.</p><p>El Instituto de Salud Carlos III ha otorgado varios proyectos de investigación y recursos humanos en el área de la salud. Algunos de los proyectos de investigación incluyen el estudio de biomarcadores de respuesta terapéutica en pacientes con dermatitis atópica y el desarrollo de métodos de estimulación cerebral profunda en pacientes con enfermedad de Parkinson. También se han financiado ensayos clínicos y estudios observacionales en áreas como hematología, oncología y dermatología. Además, se han publicado varios artículos científicos en revistas especializadas.</p><p>Se presenta una lista de publicaciones científicas en diversos campos médicos, incluyendo dermatología, farmacia, hematología, medicina interna, neurología, obstetricia y ginecología, oftalmología y oncología. Las publicaciones abarcan una variedad de temas, incluyendo la efectividad de tratamientos, factores de riesgo, precisión diagnóstica y pautas de tratamiento.</p><p>El artículo discute la situación actual de la formación especializada en pediatría y sus áreas específicas, destacando los desafíos y necesidades. Otro artículo explora el impacto económico del Acceso Transradial (TRA) versus el Acceso Transfemoral (TFA) para procedimientos neurovasculares en España. También hay un artículo sobre avances en radiología musculoesquelética. Además, hay artículos sobre disruptores ambientales en hospitales y el sueño de los cuidadores durante la hospitalización, así como el impacto pronóstico de la testosterona sérica en el cáncer de próstata metastásico hormonalmente no tratado. Por último, hay artículos sobre el impacto de una segunda resonancia magnética y una nueva biopsia en pacientes con biopsia dirigida.</p><p>La newsletter contiene información sobre la producción científica, proyectos, cursos, ensayos clínicos, premios y noticias de interés del el Hospital Universitario Virgen de las Nieves de Granada. Se trata de una revista digital mensual que proporciona contenido para ejecutivos de hospitales y sistemas de salud. El boletín está disponible en formato de archivo Adobe PDF y se puede descargar desde el sitio web del hospital (https://www.huvn.es/investigacion/formacion_y_divulgacion/newsletter_huvn_investiga).</p&gt

Use of social media by Spanish hospitals: perceptions, difficulties, and success factors

This exploratory study has two aims: (1) to find out if and how social media (SM) applications are used by hospitals in Spain and (2) to assess hospital managers' perception of these applications in terms of their evaluation of them, reasons for use, success factors, and difficulties encountered during their implementation. A cross-sectional survey has been carried out using Spanish hospitals as the unit of analysis. Geographical differences in the use of SM were found. Social networks are used most often by larger hospitals (30% by medium-size, 28% by large-size). They are also more frequently used by public hospitals (19%, p<0.01) than by private ones. Respondents with a negative perception of SM felt that there is a chance they may be abused by healthcare professionals, whereas those with a positive perception believed that they can be used to improve communication both within and outside the hospital. Reasons for the use of SM include the idea of maximizing exposure of the hospital. The results show that Spanish hospitals are only just beginning to use SM applications and that hospital type can influence their use. The perceptions, reasons for use, success factors, and difficulties encountered during the implementation of SM mean that it is very important for healthcare professionals to use SM correctly and adequately.We would like to thank the hospital managers, directors, and staff in the social communication, public relations, information technology, and management departments who took part in the survey. This work was supported by Grant Number SAS-111 217 from the Consejeria de Salud, a component of the Junta de Andalucia.Bermudez-Tamayo, C.; Alba-Ruiz, R.; Jimenez-Pernett, J.; Francisco Garcia-Gutierrez, J.; Traver Salcedo, V.; Yubraham-Sanchez, D. (2013). Use of social media by Spanish hospitals: perceptions, difficulties, and success factors. Telemedicine and e-Health. 19(2):137-145. https://doi.org/10.1089/tmj.2012.0066S13714519

Unraveling Bicuspid Aortic Valve Enigmas by Multimodality Imaging : Clinical Implications

Multimodality imaging is the basis of the diagnosis, follow-up, and surgical management of bicuspid aortic valve (BAV) patients. Transthoracic echocardiography (TTE) is used in our clinical routine practice as a first line imaging for BAV diagnosis, valvular phenotyping and function, measurement of thoracic aorta, exclusion of other aortic malformations, and for the assessment of complications such are infective endocarditis and aortic. Nevertheless, TTE is less useful if we want to assess accurately other aortic segments such as mid-distal ascending aorta, where computed tomography (CT) and magnetic resonance (CMR) could improve the precision of aorta size measurement by multiplanar reconstructions. A major advantage of CT is its superior spatial resolution, which affords a better definition of valve morphology and calcification, accuracy, and reproducibility of ascending aorta size, and allows for coronary artery assessment. Moreover, CMR offers the opportunity of being able to evaluate aortic functional properties and blood flow patterns. In this setting, new developed sequences such as 4D-flow may provide new parameters to predict events during follow up. The integration of all multimodality information facilitates a comprehensive evaluation of morphologic and dynamic features, stratification of the risk, and therapy guidance of this cohort of patient

Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection: a multisite retrospective study

BACKGROUND: The optimal antibiotic regimen for Pseudomonas aeruginosa bacteremia is controversial. Although β-lactam monotherapy is common, data to guide the choice between antibiotics are scarce. We aimed to compare ceftazidime, carbapenems, and piperacillin-tazobactam as definitive monotherapy. METHODS: A multinational retrospective study (9 countries, 25 centers) including 767 hospitalized patients with P. aeruginosa bacteremia treated with β-lactam monotherapy during 2009-2015. The primary outcome was 30-day all-cause mortality. Univariate and multivariate, including propensity-adjusted, analyses were conducted introducing monotherapy type as an independent variable. RESULTS: Thirty-day mortality was 37/213 (17.4%), 42/210 (20%), and 55/344 (16%) in the ceftazidime, carbapenem, and piperacillin-tazobactam groups, respectively. Type of monotherapy was not significantly associated with mortality in either univariate, multivariate, or propensity-adjusted analyses (odds ratio [OR], 1.14; 95% confidence interval [CI], 0.52-2.46, for ceftazidime; OR, 1.3; 95% CI, 0.67-2.51, for piperacillin-tazobactam, with carbapenems as reference in propensity adjusted multivariate analysis; 542 patients). No significant difference between antibiotics was demonstrated for clinical failure, microbiological failure, or adverse events. Isolation of P. aeruginosa with new resistance to antipseudomonal drugs was significantly more frequent with carbapenems (36/206 [17.5%]) versus ceftazidime (25/201 [12.4%]) and piperacillin-tazobactam (28/332 [8.4%] (P = .007). CONCLUSIONS: No significant difference in mortality, clinical, and microbiological outcomes or adverse events was demonstrated between ceftazidime, carbapenems, and piperacillin-tazobactam as definitive treatment of P. aeruginosa bacteremia. Higher rates of resistant P. aeruginosa after patients were treated with carbapenems, along with the general preference for carbapenem-sparing regimens, suggests using ceftazidime or piperacillin-tazobactam for treating susceptible infection

Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study

This study aimed to evaluate risk factors for 30-day mortality among hospitalised patients with Pseudomonas aeruginosa bacteraemia, a highly fatal condition. A retrospective study was conducted between 1 January 2009 and 31 October 2015 in 25 centres (9 countries) including 2396 patients. Univariable and multivariable analyses of risk factors were conducted for the entire cohort and for patients surviving ≥48 h. A propensity score for predictors of appropriate empirical therapy was introduced into the analysis. Of the 2396 patients, 636 (26.5%) died within 30 days. Significant predictors (odds ratio and 95% confidence interval) of mortality in the multivariable analysis included patient-related factors: age (1.02, 1.01–1.03); female sex (1.34, 1.03–1.77); bedridden functional capacity (1.99, 1.24–3.21); recent hospitalisation (1.43, 1.07–1.92); concomitant corticosteroids (1.33, 1.02–1.73); and Charlson comorbidity index (1.05, 1.01–1.93). Infection-related factors were multidrug-resistant Pseudomonas (1.52, 1.15–2.1), non-urinary source (2.44, 1.54–3.85) and Sequential Organ Failure Assessment (SOFA) score (1.27, 1.18–1.36). Inappropriate empirical therapy was not associated with increased mortality (0.81, 0.49–1.33). Among 2135 patients surviving ≥48 h, hospital-acquired infection (1.59, 1.21–2.09), baseline endotracheal tube (1.63, 1.13–2.36) and ICU admission (1.53, 1.02–2.28) were additional risk factors. Risk factors for mortality among patients with P. aeruginosa were mostly irreversible. Early appropriate empirical therapy was not associated with reduced mortality. Further research should be conducted to explore subgroups that may not benefit from broad-spectrum antipseudomonal empirical therapy. Efforts should focus on prevention of infection, mainly hospital-acquired infection and multidrug-resistant pseudomonal infection